Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: J Hepatol. 2011 Feb 18;55(4):838–845. doi: 10.1016/j.jhep.2010.12.043

Figure 5. Acquisition of EMT in CD133−/ALDHlowHep3B, HLE and HLF cells.

Figure 5

FACS-enriched CD133+/ALDHhigh or CD133−/ALDHlow subpopulations were stained with either Cy5-conjugated monoclonal antibodies against E-cadherin or vimentin in red. Cy5-stained images were overlaid with DAPI nuclear counter-staining in blue. Hep3B and HLF (20×), HLE (10×).

HHS Vulnerability Disclosure